Article info
PDFEconomics
Enoxaparin had lower costs than unfractionated heparin for acute coronary syndrome
Citation
Enoxaparin had lower costs than unfractionated heparin for acute coronary syndrome
Online issue publication
December 06, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions